StonvexLoading…
StonvexStonvexStonvexCore line items from TBCH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2023 2023-09-30 |
|---|---|---|---|---|
Revenue | $319.91M | $372.77M | $258.12M | $59.16M |
Operating Income | $27.52M | $20.03M | $-16.44M | Not available |
Net Income | $15.73M | $16.18M | $-17.68M | $-3.61M |
EPS (Diluted) | $0.77 | $0.78 | $-1.03 | $-0.21 |
Total Assets | $269.05M | $298.86M | $149.97M | Not available |
Total Liabilities | $140.56M | $178.26M | $64.89M | Not available |
Cash & Equivalents | $16.96M | $12.99M | $18.73M | Not available |
Free Cash Flow OCF − CapEx | $34.04M | $847.00K | $24.89M | Not available |
Shares Outstanding | 19.19M | 19.96M | 17.53M | Not available |